Scott Moomaw
About Scott Moomaw
Scott Moomaw is the Chief Commercial Officer at Liquidia, having joined the company in November 2020. He has extensive experience in the pharmaceutical industry, including co-founding RareGen and holding senior marketing roles at Opko Health and United Therapeutics.
Chief Commercial Officer at Liquidia
Scott Moomaw joined Liquidia in November 2020 as the Chief Commercial Officer. In his current role, Scott is responsible for overseeing the company's commercial strategy and driving business growth. He brings extensive experience in the biotechnology and pharmaceutical industries, fostering innovation and market expansion efforts at Liquidia. His leadership focus is on enhancing the market presence of Liquidia's products and services.
Co-Founder and Chief Operations Officer at RareGen
Before joining Liquidia, Scott Moomaw co-founded RareGen in August 2018 and served as the Chief Operations Officer. During his time at RareGen, he played a pivotal role in launching Treprostinil, a medication used to treat pulmonary arterial hypertension (PAH). As COO, he was integral in shaping the company’s operational strategies and ensuring the successful commercialization of the drug.
Vice President of Marketing Experience
Scott Moomaw has held significant marketing leadership roles in his career. As Vice President of Marketing at Opko Health, he contributed to the company's marketing strategies. Prior to that, he was Vice President of Marketing at United Therapeutics, where he managed the marketing of key products for PAH, including Remodulin, Tyvaso, and Orenitram. His expertise in managing marketing for critical pharmaceuticals is well-recognized in the industry.
Sales and Marketing Roles at Eli Lilly
Scott Moomaw spent over a decade at Eli Lilly, where he held various roles in sales and marketing. His tenure at Eli Lilly provided him with a strong foundation in pharmaceutical sales, marketing strategy, and team leadership. This experience has been instrumental in shaping his career and his approach to commercialization in later roles.
Educational Background
Scott Moomaw holds an MBA from the University of Michigan, which has equipped him with essential business management and strategic planning skills. Additionally, he earned a Bachelor of Science (B.S.) from Miami University. His educational background has provided a solid academic foundation to support his extensive career in the pharmaceutical and biotechnology industries.